Gyn-patho.de

Schriftenverzeichnis Prof. Dr. med. Friedrich Kommoss
Originalarbeiten, Fallberichte und Übersichten
(in Zeitschriften mit wissenschaftlichem Beirat)
1. Kommoss F., Mercer L., Schmidt R.A., Talerman A.: Granular cel tumor of the breast mimicking carcinoma in pregnancy. Obstet Gynecol 73, 898-900, 1989 2. Kommoss F., Franklin W.A., Talerman A.: Estrogen and progesterone receptors in endodermal sinus (yolk sac) tumor. Evaluation of immunocytochemical and biochemical methods. J Reproductive Medicine 34, 943-945, 1989 3. Kommoss F., Bibbo M., Col ey M., Dytch H.E., Franklin W.A., Holt J.A., Wied G.L.: Assessment of hormone receptors in breast carcinoma by immunocytochemistry and image analysis. I. Progesterone receptors. Analyt Quant Cytol Histol 11, 298-306, 1989 4. Col ey M., Kommoss F., Bibbo M., Dytch H.E., Holt J.A., Wied G.L., Franklin W.A.: Assessment of hormone receptors in breast carcinoma by immunocytochemistry and image analysis. II. Estrogen receptors. Analyt Quant Cytol Histol 11, 307-314, 1989 5. Kommoss F., Bibbo M., Talerman A.: Nuclear deoxyribonucleic acid content (ploidy) of endodermal sinus (yolk sac) tumor. Lab Investigation 62, 223-231, 1990 6. Kommoss F., Emond J., Talerman A.: Ruptured Mature Cystic Teratoma of the Ovary with Recurrences in the Liver and Colon after 17 Years. J Reproductive Medicine 35, 827-831, 1990 7. Kommoss F., Col ey M., Hart C., Franklin W.A.: In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, PDGFr-ß-subunit. Molecular and Cel ular Probes 4, 11-23, 1990 8. Kommoss F., Wintzer H.O., Von Kleist S., Kohler M., Walker R., Langton B., Van Tran K., Pfleiderer A., Bauknecht T.: In situ distribution of Transforming Growth Factor-alpha (TGF-alpha) in normal human tissues and in malignant tumours of the ovary. J Pathology 162, 223-230, 1990 9. Bauknecht T., Birmelin G., Kommoss F.: Clinical significance of oncogenes and growth factors in ovarian carcinomas. J Steroid Biochem Molec Biol 37, 855-862, 1990 10. Kommoss F., Pfisterer J., Thome M., Geyer H., Sauerbrei W., Pfleiderer A.: Estrogen and progesterone receptors in ovarian neoplasms: discrepant results of immunohistochemical and biochemical results. Int J Gynecol Cancer 1, 147-153, 1991 11. Pfisterer J., Runge H.M., Kommoss F., Herbst E.W., Hil emanns H.G.: Primäre pulmonale Hypertonie und Schwangerschaft. Geburtsh u Frauenheilk 51, 236-238, 1991 12. Karck U., Kommoss F., Henne K., Runge M., Pfleiderer A.: Rezidivierender Thekazel -Tumor. 13. Bauknecht T., Kommoss F., Birmelin G., von Kleist S., Kohler M, Pfleiderer A.: Expression analysis of EGF-R and TGF-alpha in human ovarian carcinomas. J Anticancer Res 11, 1523-1528, 1991 14. DuBois A., Meerpohl H.G., Vach W., Kommoss F.G.M., Fenzl E., Pfleiderer A.: Course, patterns, and risk-factors for chemotherapy-induced emesis and nausea in cisplatin-pretreated patients: a study with the 5HT3-receptor antagonist ondansetron. Eur J Cancer 28, 450-457, 1992 15. Kohler M., Bauknecht T., Grimm M., Birmelin G., Kommoss F., Wagner E.: Epidermal growth factor receptor and Transforming Growth Factor Alpha expression in human ovarian carcinomas. Eur J Cancer 28A, 1432-1437, 1992 16. Kohler M., Bauknecht T., Grimm M., Birmelin G., Kommoss F., Wagner E.: Epidermal growth factor receptor and Transforming Growth Factor Alpha expression in human ovarian carcinomas. Eur J Cancer 28A, 1432-1437, 1992 17. Madjar H., Prömpeler H., Kommoss F., Göppinger A.: Ergänzt der Farbdoppler die Mammadiagnostik? Radiologe 32, 568-575, 1992 18. Kommoss F., Pfisterer J., Thome M., Sauerbrei W., Pfleiderer A.: Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects. Gynecol Oncol 47, 317-322, 1992 19. Bauknecht T., Angel P., Kommoss F., Birmelin G., Kohler M., Pfleiderer A., Wagner E.: Gene structure and expression analysis of Epidermal Growth Factor Receptor (EGF-R), Transforming Growth Factor-Alpha (TGF-?), MYC, JUN, and Metal othionein (MT) in human ovarian carcinomas. Classification of malignant phenotypes. Cancer 71, 419-429, 1993 20. Ikenberg H., Teufel G., Schmitt B., Kommoss F., Stanimirovic B, Pfleiderer A: Human Papil omavirus DNA in distant metastases of cervical cancer. Gynecol Oncol 48, 56-60, 1993 21. Bauknecht T., Kiechle-Schwarz M., Kommoss F., Wölfle J., Birmelin G., Angel P.: Ovarian adenocarcinomas express members of different cytokine pathways: analysis and quantification of transcripts from the TGF-? and M-CSF/FMS pathways and the transcription factor cJUN. Int J Oncol 2, 797-802, 1993 22. Madjar H., du Bois A., Kommoss F., Meerpohl H.G., Pfleiderer A: Implementation of Doppler ultrasound for therapy control of breast malignancies treated with chemotherapy. Onkologie 16, 183-188, 1993 23. Kommoss F., DeGregorio G., Strittmatter B., Pfisterer J., Karck U., Breckwoldt M.: Geburtshilfliche Komplikationen, Frequenz und Indikationen der Kaiserschnittentbindung bei Uterus Myomatosus. Geburtsh u Frauenheilk 53, 564-567, 1993 24. Thompson J., Mössinger S., Reichardt V., Engels U., Beauchemin N., Kommoss F., von Kleist S., Zimmermann W.: A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members. Int J Cancer 55, 311-319, 1993 25. Kommoss F., Pfisterer J., Idris T., Giese E., Schäfer W., Pfleiderer A.: Steroid receptors in carcinoma of the breast: comparison of immunocytochemical and biochemical results and their effect upon short-term prognosis. Analyt Quant Cytol Histol, 16, 203-210, 1994.
26. Prömpeler H.J., Madjar H., DuBois A., Lattermann U., Wilhelm C., Kommoss F., Pfleiderer A.: Transvaginal sonography of myometrial invasion depth in endometrial cancer. Acta Obstet Gynecol Scand 73, 343-346, 1994 27. Wetzka B., Schäfer W., Kommoss F., Bettendorf H., Nüsing R., Breckwoldt M., Zahradnik H.P.: Immunohistochemical localization of thromboxane synthase in human intrauterine tissues. Placenta 15, 389-98, 1994 28. Kommoss F., Wölfle J., Bauknecht T., Pfisterer J., Kiechle-Schwarz M., Pfleiderer A., Kiehl R., Kacinski B.M.: Coexpression of M-CSF transcripts, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adeno-carcinomas of the ovary. J Pathol 174, 111-9, 1994 29. Pfisterer J., Kommoss F., Sauerbrei W., Renz H., DuBois A., Kiechle-Schwarz M., Pfleiderer A.: Cel ular DNA content and survival in advanced ovarian carcinoma. Cancer 74, 2509-15, 1994 30. Kiechle-Schwarz M., Bauknecht T., Karck U., Kommoss F., du Bois A., Pfleiderer A.: Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Gynecol Oncol 55, 198-205, 1994 31. Kommoss F., Kiechle-Schwarz M., DuBois A., Pfisterer J., Spinner D., Madjar H., Bauknecht T., Pfleiderer A., Kacinski B.M.: Co-cultivation of ovarian cancer cel s with dermal fibroblasts induces expression of sex steroid receptor transcripts and protein. Int J Gynecol Cancer 5, 101-6, 1995 32. Pfisterer J., Kommoss F., Sauerbrei W., Rendl I., Kiechle M., Kleine W., Pfleiderer A.: Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol 58, 149-156, 1995 33. Langer M., Buitrago-Tel ez C.H., Schulze C., Gufler H., Mundinger A., Kommoss F.: Digital optical card. A promising technology for documentation and communication of images. Acta Radiologica 36, 674-678, 1995 34. Pfisterer J., Kommoss F., Sauerbrei W., Menzel D., Giese E., Kiechle M., Hilgarth M., Pfleiderer A.: DNA flow cytometry in node-positive breast cancer. Analyt Quant Cytol Histol 17, 406-412, 1995 35. Pfisterer J., Kommoss F., Sauerbrei W., Baranski B., Kiechle M., Ikenberg H., Du Bois A., Pfleiderer A.: DNA flow cytometry in stage IB and II cervical carcinoma. Int J Gynecol Cancer 6, 54-60, 1996 36. DuBois A., Kommoss F.G.M., Pfisterer J., Lück H.J., Meerpohl H.G.: Paclitaxel-induced "recal " soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses. Gynecol Oncol 60, 94-6, 1996 37. Schneider B., Laubenberger J., Kommoss F., Madjar H., Gröne K., Langer M.: Multiple giant fibroadenoms: clinical presentation and radiologic findings. Gynecol Obstet Invest 43, 278-80, 1997 38. Kommoss F., Oliva E., Bhan A.K., Young R.H., Scul y R.E.: Inhibin expression in ovarian tumors and tumor-like lesions. An immunohistochemical study. Mod Pathol 11, 656-664, 1998 39. Meinhold-Heerlein I., Brandstetter T., Kommoss F., Bettendorf H., Hagedorn M., Bauknecht T.: Localization of cytokeratin 10 mRNA in human epidermis using nonradioactive in situ hybridization as a routine method. Arch Dermatol Res 290, 286-288, 1998 40. Kommoss F., Karck U., Prömpeler H. Pfisterer J.,Kirkpatrick C.J.: Steroid receptor expression in endometria from women treated with tamoxifen. Gynecol Oncol 70, 188-191, 1998 41. Schuler M., Rochlitz C., Horowitz J.A., Schlegel J., Perrouchoud A.P., Kommoss F., Bol iger T., Kauczor H.U., Dalquen P., Fritz M.A., Swanson S., Herrmann R., Huber C.: A phase I study of adenovirus mediated wild type p53 gene transfer in patients with advanced non-smal cel lung cancer. Human Gene Ther 9, 2075-2082, 1998 42. Kommoss F., Dries V., Schmidt M., Kirkpatrick C.J., Knapstein P.G., Höckel M.: Rhabdoid Tumor der Vulva - eine ungewöhnliche, klinisch fehlgedeutete hochmaligne Läsion. Geburtsh u Frauenheilk 58, 169-72, 1998 43. Kommoss F., Dittrich M., Hofmann-v.Kapp-herr S., Kriegsmann J., Coerdt W., Müntefering H.: Ovarian Smal cel carcinoma, hypercalcemic type. Report of a highly aggressive tumor with uncertain histogenesis. Elec J Pathol Histol 982:11, 1998 44. Kommoss F., Pfisterer J., Peters F., Kirkpatrick C.J., Hilgarth M.: Ektope Deziduareaktion – möglicher Anlaß zur kolposkopischen, histologischen und intraoperativen Fehldiagnose. Geburtsh u Frauenheilk 58, 446-450, 1998 45. Kommoss F.: Ovarialkarzinom – Histologie und Prognosefaktoren. Onkologe 4:1101-1113, 1998 46. Kommoss F., Schmidt M., Merz. E., Knapstein P.G., Young R.H., Scul y R.E.: Ovarian endometrioid- like yolk sac tumor treated by surgery alone, with recurrence at 12 years. Gynecol Oncol 72:421-4, 1999 47. Gaumann A., Marx J., Bohl J., Kommoss F., Köhler H., Tews D.S.: Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinical y inapparent gal bladder carcinoma. Pathol Res Pract 195, 495-9, 1999 48. Pfisterer J., Kommoss F.: Seltene Tumoren des weiblichen Genitale. Onkologe 5:963-967, 1999 49. Kiechle M., Hinrichs M., Jacobsen A., Lüttges J., Pfisterer J., Kommoss F., Arnold N.: Genetic imbalances in precursor lesions of endometrial cancer detected by CGH. Am J Pathol, 156, 1827-1833, 2000 50. Kommoss F., Oliva E., Bittinger F., Kirkpatrick C.J., Amin M.B., Bhan, A.K., Young R.H., Scul y R.E.: Inhibin-a, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Hum Pathol, 2000, 31, 1055-1061 51. Lehr H.A., Folpe A., Yaziji H., Kommoss F., Gown A.M.: Cytokeratin 8 immunostaining pattern and E- Cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol, 2000, 114, 190-196 52. Kriegsmann J., Coerdt W., Kommoss F., Beetz R., Hal ermann C., Müntefering H.: Renal tubular dysgenesis (RTD) - an important cause of the oligohydramnion-sequence. Report of 3 cases and review of the literature. Pathol Res Pract 196: 861-5, 2000 53. Organgruppe Ovar, Arbeitsgemeinschaft Gynäkologische Onkologie (Bauknecht T., Breitbach G.P., duBois A., Emons G., Grischke E.M., Jäger W., Kommoss F., Kreienberg R., Kuhn W., Lück H.J., Meden H., Meerpohl H.G., Meier W., Pfisterer J., Schröder W., Wagner U.: Intersdisziplinäre kurzgefasste Leitlinie der Deutschen Krebsgesel schaft und der Deutschen Gesel schaft für Gynäkologie und Geburtshilfe: Maligne Ovarialtumoren. Frauenarzt 2000;41:909-915 sowie InFoOnkologie 2000;3:174-179 54. Schuler M., Herrmann R., de Greve J.L.P., Stewart K., Gatzemeier U., Stewart D.J., Laufman L., Gral a R., Kubal J., Buhl R., Heussel C.P., Kommoss F., Perruchoud A.P., Shepherd F.A., Fritz M.A., Horowitz J.A., Huber C., Rochlitz C.: Adenovirus-mediated wild type p53 gene transfer in patients receiving chemotherapy for advanced non-smal cel lung cancer: results of a multicenter phase II study. J Clin Oncol, 19(6), 1750-1758, 2001 55. Kommoss F., Sapi E., Flick M.B., Kacinski B.M.: Phospho-fms expression in ovarian sex cord- stromal tumors. Geburtsh u Frauenheilk, 61, 1-4, 2001 56. Koeppen C., Peters F., Kommoss F.: Mammakarzinom mit osteoklastären Riesenzel en - Gefahr der präoperativen Fehldeutung. Breast cancer with osteoclast-like giant cel s interpreted as a cyst: a case report. Geburtsh u Frauenheilk 61:96-99, 2001 57. Gaumann A., Hansen T., Köhler H.H., Kommoss F., Mann W., Maurer J., Kirkpatrick C.J., Kriegsmann J.: The expression of cathepsins in osteaclast-like giant cel s of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract 197; 257-262, 2001 58. Kommoss F., Oliva E., Schmidt D., Bittinger F., Kirkpatrick C.J.: Expression of Mül erian inhibiting substance (MIS), CD99, and HEA125 immunoreactivity in ovarian tumors. Geburtsh u Frauenheilk 61:274-279, 2001 59. Kommoss F., Schmidt D., Coerdt W., Olert J., Müntefering H.: Immunohistochemical expression analysis of inhibin-a and ß subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua. Int J Gynecol Pathol 20; 380-385, 2001 60. Kommoss F., Richter B., Breitbach G.P.: Borderline Tumoren des Ovars. Gynäkologe 34:1003-1012, 61. Burg J., Kommoss F., Bittinger F., Mol R., Kirkpatrick C.J.: Mature cystic teratoma of the ovary with struma and a benign Brenner tumor: A case report with immunohistochemical characterization. Int J Gynecol Pathol 21:74-77, 2002 62. Kommoss F.: Miscel aneous mesenchymal tumours and tumour-like lesions of the uterus. 63. Breitbach G.P., Kommoss F.: Die Borderline Tumoren des Ovars. Onkologe 8:1149-1159, 2002 64. Riener E.K., Arnold N., Kommoss F., Lauinger S., Pfisterer J. The prognostic and predictive value of immunohistochemical y detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study. Gynecol Oncol 95:89-94, 2004 65. Kommoss F., Kommoss S., Schmidt D., Trunk-Gehmacher M., Pfisterer J., du Bois A.: Survival benefit for patients with advanced-stage transitional cel carcinomas vs. other subtypes of ovarian carcinoma after standardized adjuvant chemotherapy. Gynecol Oncol 97:195-9, 2005 66. Schmidt D., Horn L.C., Kommoss F.: Neuroendocrine carcinomas of the cervix. Pathologe 26:262-5, 67. Schmidt D., Horn L.C., Kommoss F.: Histopathology of squamous cel carcinoma and adenocarcinoma of the uterine cervix. Pathologe 26:255-61, 2005 68. Horn L.C., Einenkel J., Hockel M., Kolbl H., Kommoss F., Lax S.F., Riethdorf L., Schnurch H.G., Schmidt D.: Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynaecologic malignancies. Pathologe 26:266-72, 2005 69. Schmalfeld B., du Bois A., Burges A., Emons G., Fink D., Gropp M., Hasenburg A., Jäger W., Kimmig R., Kiechle M., Kommoss F., Kreienberg R., Kuhn W., Lück H.J., Meier W., Münstedt K., Ortmann O., Pfisterer J., Richter B., Runnebaum I., Schröder W., Sehouli J., Tanner B., Wagner U., Weis J.: Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO. Diagnosis and Treatment of Malignant Ovarian Tumors 2005: Recommendations of the Kommission Ovar of the AGO. Zentralbl Gynakol 128:11-7, 2006 70. Kommoss S, du Bois A, Schmidt D, Parwaresch R, Pfisterer J, Kommoss F. Chemotherapy may be more effective in highly proliferative ovarian carcinomas- A translational research subprotocol of a prospective randomized phase III study (AGO- OVAR 3 protocol). Gynecol Oncol 103:67-71, 2006 71. Horn LC, Einenkel J, Hockel M, Kolbl H, Kommoss F, Lax SF, Reich O, Riethdorf L, Schmidt D. [Pathoanatomical preparation and reporting for dysplasias and cancers of the cervix uteri: cervical biopsy, conization, radical hysterectomy and exenteration.] Pathologe. 2006 Jul 13; [Epub ahead of print] 72. Kommoss S, du Bois A, Ridder R, Trunk MJ, Schmidt D, Pfisterer J, Kommoss F. Independent prognostic significance of cel cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimal y debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Br J Cancer 29:306-13, 2007 73. Schmidt D., Kommoss F.: Diagnosis and differential diagnosis of granulosa cel tumor. Pathologe 28, 74. Schmidt D., Kommoss F.: Teratoma of the ovary : Clinical and pathological differences between mature and immature teratomas. Pathologe 28, 203-8, 2007 75. Kommoss F., Schmidt D.: Immunohistochemical sex cord markers : Description and use in the differential diagnosis of ovarian tumors. Pathologe 28, 187-94, 2007 76. Kommoss F., Kommoss S., Eichhorn J., Schmidt D.: Transitional cel carcinoma of the ovary : Morphological and clinical features. Pathologe, 28, 209-14, 2007 77. Vavilis D., Papadopoulos N., Agorastos T., Efstratiou I., Kommoss F., Bontis I.N.: Primary ovarian angiosarcoma-review of the literature and report of a case with coexisting chylothorax. Eur J Gynaecol Oncol 28, 287-9, 2007 78. Wentzensen N., du Bois A., Kommoss S., Pfisterer J., von Knebel Doeberitz M., Schmidt D., Kommoss F.: No Metastatic Cervical Adenocarcinomas in a Series of p16INK4a-Positive Mucinous or Endometrioid Advanced Ovarian Carcinomas: An Analysis of the AGO Ovarian Cancer Study Group. Int J Gynecol Pathol 27:18-23, 2008 79. Engels K., Knauer SK, Loibl S., Fetz V., Harter P., Schweitzer A., Fisseler-Eckhoff A., Kommoss F., Hanker L., Nekljudova V., Hermanns I., Kleinert H., Mann W., du Bois A., Stauber RH: NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 68:5159-66, 2008 80. Dondog B., Clifford GM, Vaccarel a S., Waterboer T., Unurjargal D., Avirmed D., Enkhtuya S., Kommoss F., Wentzensen N., Snijders PJ, Meijer CJ, Franceschi S., Pawlita M.: Human papil omavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 17:1731-8, 2008 81. Nehls K., Vinokurova S., Schmidt D., Kommoss F., Reuschenbach M., Kisseljov F., Einenkel J., von Knebel Doeberitz M., Wentzensen N.: p16 methylation does not affect protein expression in cervical carcinogenesis. Eur J Cancer 44:2496-505, 2008 82. Kommoss F., Kommoss S., Schmidt D., du Bois A., Pfisterer J.: Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas? Pathologe 29, Suppl 2:157-9, 2008 83. Engels K., du Bois A., Harter P., Fisseler-Eckhoff A., Kommoss F., Stauber R., Kaufmann M., Nekljudova V., Loibl S.: VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. J Clin Pathol 62:448-54, 2009 84. Kommoss S., Schmidt D., Kommoss F., Hedderich J., Harter P., Pfisterer J., du Bois A.: Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).Virchows Arch 454:249-56, 2009 85. Pfisterer J., Du Bois A., Bentz EK, Kommoss F., Harter P., Huober J., Schmalfeldt B., Burchardi N., Arnold N., Hilpert F.: Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany. Int J Gynecol Cancer 19:109-15, 2009 86. Staats PN, Garcia JJ, Dias-Santagata DC, Kuhlmann G., Stubbs H., McCluggage WG, De Nictolis M., Kommoss F., Soslow RA, Iafrate AJ, Oliva E.: Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCT) Lack the JAZF1-JJAZ1 Translocation Frequently Seen in Endometrial Stromal Tumors. Am J Surg Pathol (Epub ahead of print), 2009

Source: http://www.gyn-patho.de/Institut/Kommoss/Originalarbeiten_Prof_Kommoss.pdf